Impact of mild to moderate elevations of alanine aminotransferase on liver stiffness measurement in chronic hepatitis B patients during antiviral therapy

Hepatology Research

Volumn 43, Issue 2, 2013, Pages 185-191

  Yan, Li Bo ^a,b   Zhu, Xia ^a,b   Bai, Lang ^a,b   Liang, Ling Bo ^a,b   Chen, En Qiang ^a,b   Du, Ling Yao ^a,b   Wang, Li Chun ^a,b   Chen, Li Yu ^a,b   Tang, Hong ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Alanine aminotransferase; Fibrosis; Hepatitis B virus; Liver biopsy; Liver stiffness

Indexed keywords

ADEFOVIR DIPIVOXIL; ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; TELBIVUDINE; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; ELASTOGRAPHY; FEMALE; HEPATITIS B; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER STIFFNESS MEASUREMENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PREMEDICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT;

EID: 84873968316     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.01068.x     Document Type: Article

References (25)

1. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45 (2): 507-39.
2. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344 (7): 495-500.
3. Castera L, Negre I, Samii K etal. Pain experienced during percutaneous liver biopsy. Hepatology 1999; 30 (6): 1529-30.
4. Rousselet MC, Michalak S, Dupre F etal. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005; 41 (2): 257-64.
5. Ziol M, Handra-Luca A, Kettaneh A etal. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41 (1): 48-54.
6. Yoneda M, Mawatari H, Fujita K etal. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis 2008; 40 (5): 371-8.
7. Marcellin P, Ziol M, Bedossa P etal. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009; 29 (2): 242-7.
8. Zhu X, Wang LC, Chen EQ etal. Prospective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infection. Dig Dis Sci 2011; 56 (9): 2742-9.
9. Fraquelli M, Branchi F. The role of transient elastography in patients with hepatitis B viral disease. Dig Liver Dis 2011; 43 (Suppl 1): S25-31.
10. Chen YP, Liang XE, Zhang Q etal. Larger biopsies evaluation of transient elastography for detecting advanced fibrosis in patients with compensated chronic hepatitis B. J Gastroenterol Hepatol 2012; 27 (7):1219-26.
11. Chan HL, Wong GL, Choi PC etal. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat 2009; 16 (1): 36-44.
12. Kim SU, Kim Y, Park JY etal. How can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B? J Clin Gastroenterol 2010; 44 (1): 66-71.
13. Arena U, Vizzutti F, Corti G etal. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008; 47 (2): 380-4.
14. Sagir A, Erhardt A, Schmitt M etal. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008; 47 (2): 592-5.
15. Fung J, Lai CL, But D etal. Reduction of liver stiffness following resolution of acute flares of chronic hepatitis B. Hepatol Int 2010; 4 (4): 716-22.
16. Liang XE, Chen YP, Zhang Q etal. Dynamic evaluation of liver stiffness measurement to improve diagnostic accuracy of liver cirrhosis in patients with chronic hepatitis B acute exacerbation. J Viral Hepat 2011; 18 (12): 884-91.
17. Chen XB, Zhu X, Chen LY etal. Accuracy of FibroScan for the diagnosis of liver fibrosis influenced by serum alanine aminotransferase levels in patients with chronic hepatitis B]. Zhonghua Gan Zang Bing Za Zhi 2011; 19 (4): 286-90.
18. Wong GL, Wong VW, Choi PC etal. Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B. J Gastroenterol Hepatol 2009; 24 (6): 1002-7.
19. Coco B, Oliveri F, Maina AM etal. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 2007; 14 (5): 360-9.
20. Chang TT, Gish RG, de Man R etal. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med 2006; 354 (10): 1001-10.
21. Lai CL, Gane E, Liaw YF etal. Telbivudine versus lamivudine in patients with chronic hepatitis B. N Engl J Med 2007; 357 (25): 2576-88.
22. Chang TT, Liaw YF, Wu SS etal. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology 2010; 52 (3): 886-93.
23. Enomoto M, Mori M, Ogawa T etal. Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: regression of liver stiffness during entecavir therapy. Hepatol Res 2010; 40 (9): 853-61.
24. Wong GL, Wong VW, Choi PC etal. On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients. Antivir Ther 2011; 16 (2): 165-72.
25. Osakabe K, Ichino N, Nishikawa T etal. Reduction of liver stiffness by antiviral therapy in chronic hepatitis B. J Gastroenterol 2011; 46 (11): 1324-34.